AIMP1 and glioblastoma: Our previous research also found that EMAP II has cytotoxicity in human GBM cells and GBM stem cells (Liu et al., 2014; Ma et al., 2015), and inhibited the viability, migration, and invasion ability of GBM cells (Chen et al., 2016).